יחס שווי פעילות לרווח לפני ריבית, מסים ופחת are.com (ARE)

Alexandria owns unique biotech clusters, ensuring reliable medical cargo logistics and high returns. The current EV/EBITDA valuation reflects market sentiment, with the metric holding at 12.47. Business stability is guaranteed by an elite staff of laboratory experts with minimal turnover. Additionally, the trust is developing research campuses through partnerships with universities and pharma behemoths.

For Alexandria (ARE), the historical EV/EBITDA chart serves as a tool to compare the total enterprise value of the business with its operating cash flow. This metric combines market capitalization and net debt, dividing them by earnings before interest, taxes, depreciation, and amortization. This allows for an assessment of the efficiency of investments in robotics and smart laboratories relative to capital expenditures. The indicator's trend determines whether the asset's current valuation is fair.